Group items tagged

Have you ever wanted to know how vaccines are sent out from a lab to your doctor's office safely? Well, believe it or not, the integrity of the vaccines relies on how they have been packed just as much as how they are being transported. And the entire process is not as simple as you may think. Traditionally, styrofoam boxes might work well to secure glass or delicate goods during transportation but when it comes to hauling vials of liquid vaccine solutions out to medical centres and hospitals; the packing process must be more rigorous-understandably. The integrity of the vaccines, being transported, must adhere to particular protocols from the second they are packed right up to the moment they are administered. This process sounds strict and that's because it is. If vaccines are not well-cared for, even during transit, then they are at risk of being contaminated or damaged therefore rendering them unusable. Incorrectly transporting vaccines, which will end up being destroyed, is something nobody wants to happen therefore vaccine transportation must be strict. One of the best ways to ensure the safe and efficient transit of medical goods, like vaccines, is by using bioprocess containers. These containers are specifically designed to maintain the integrity of sensitive biological materials throughout their journey.

The UK government has awarded a £1.7 million contract to Ensilicated Technologies Ltd (EnsiliTech), a University of Bath spinout company dedicated to making vaccines safer, to develop the world's first thermally stable mRNA vaccine. mRNA vaccines have a huge potential to prevent infectious diseases and a range of previously unpreventable conditions, but currently, these vaccines require ultracold storage, needing to be kept at -70 or even -80 °C. The company's ensilication technology allows vaccines and other biological materials to be transported and stored without the use of refrigeration. Dr Asel Sartbaeva, co-founder and CEO at EnsiliTech, believes that the technology could save tens of thousands of lives every year. She commented: "We're so proud to have won this important government grant."

Britain will offer a Covid-19 booster shot to all adults and could halve the dose interval for booster jabs from six to three months in a bid to accelerate its vaccination programme amid concern over the new Omicron coronavirus variant, as number of new cases found in the country rise. The move, backed by a scientific advisory body and Health Secretary Sajid Javid, comes as ministers scramble to react swiftly to the new variant, which was first detected in South Africa. Prime minister Boris Johnson has responded to the emergence of Omicron by making mask-wearing compulsory in shops and on public transport in England. Until now, only adults in the UK aged 40 and above were eligible for a booster dose six months after their last. But that timeframe will now be halved to three months, alongside the programme's expansion to all over-18s, with priority given to older people. "These measures will protect more people, more quickly and make us better protected as a nation," Javid told MPs.

New mask mandates and other measures aimed at curbing the spread of the Omicron coronavirus variant came into England today, as Prime Minister Boris Johnson eyes an expanded booster programme to help increase protection against Covid-19. From Tuesday morning (November 30), face masks are compulsory on transport and in shops, banks and hair salons. All international travellers must take a PCR test by the end of the second day after they arrive, and self-isolate until they get their result. That is in addition to restrictions on arrivals from 10 southern African countries, who have to enter hotel quarantine. Britain has reported 11 cases of the Omicron variant so far, and while the government says this number will rise, it says it is important to slow its spread until more is known about the variant's transmissibility and impact on vaccines.